RxDoctor Payments Data

Sheree Lopez, MD

Family Medicine · Columbus, OHNPI 1376528661

Payments from drug & device makers

$1,814in general payments, 2019–2025

Across 113 payments — averaging $16.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$681
  • Merck$243
  • Novo Nordisk$192
  • AbbVie$165
  • Shield Therapeutics Inc$80
  • Amgen$79
  • plus $373 from 12 others

What the payments were for

  • Food & beverage$1,808100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,814 in reported general payments places this provider in the 70th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$44,842
Medicare patients
80
Services billed
1,368

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide17$32,467
JardianceEmpagliflozin19$26,309
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$23,317
JanuviaSitagliptin Phosphate17$22,395
Tresiba Flextouch U-100Insulin Degludec15$16,498
EliquisApixaban15$14,172
FarxigaDapagliflozin Propanediol12$10,292
SymbicortBudesonide/Formoterol Fumarate12$6,216
ShingrixVaricella-Zoster Ge/As01b/Pf22$4,859
Dexlansoprazole DrDexlansoprazole17$3,810
Atorvastatin Calcium306$3,214
Albuterol Sulfate HfaAlbuterol Sulfate68$2,400
Levetiracetam17$2,138
Gabapentin83$1,833
Amlodipine Besylate302$1,704

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$19$32,46717 claims
GSKTrelegy Ellipta, Shingrix$36$28,17644 claims
MerckJanuvia$243$22,39517 claims
AstraZenecaFarxiga, Symbicort$681$16,50824 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →